These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4850070)

  • 41. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pathochemistry of cerebral ageing].
    Quadbeck G
    Verh Dtsch Ges Pathol; 1968; 52():64-74. PubMed ID: 4182318
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
    Ritschel WA; Mandybur TI; Grummich KW; Means ED
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study of the antihypoxic effect of eburnamonine in acute and recurrent anoxia on the cerebral electric activity in curarized rats. Comparison with vincamine].
    Van Den Driessche J; Linée P; Lacroix P; Le Pollès JB
    C R Seances Soc Biol Fil; 1977; 171(5):1081-7. PubMed ID: 146550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 46. The cerebral hemodynamic effect of Vincamine.
    Depresseux JC
    Acta Neurol Scand Suppl; 1977; 64():408-9. PubMed ID: 268852
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers.
    Lim CC; Cook PJ; James IM
    Br J Clin Pharmacol; 1980 Jan; 9(1):100-1. PubMed ID: 7356869
    [No Abstract]   [Full Text] [Related]  

  • 48. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 49. [Investigation of vasoactive agents with indole skeletons at Richter Ltd].
    Kárpáti E; Bíró K; Kukorelli T
    Acta Pharm Hung; 2002; 72(1):25-36. PubMed ID: 12426785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
    Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of a cerebral oxygenator drug in chronic encephalopathies (apropos of the trial of vincamine)].
    Fossey F; Pasquier C
    Rev Neuropsychiatr Infant; 1972; 20(11):887-91. PubMed ID: 4650072
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

  • 53. [Some aspects of carbohydrate metabolism of the brain of closed cranio-cerebral injury].
    Promyslov MSh; Tigranian RA; Evsina NIu
    Vopr Med Khim; 1967; 13(3):295-9. PubMed ID: 5597205
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebral regulation-cerebral regulators.
    Braun P
    Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of hexobendine on cerebral blood flow and metabolism. A contribution towards the understanding of the mechanism of action of cerebral vasodilatory drugs.
    Kraupp O; Nell G; Raberger G; Stühlinger W
    Arzneimittelforschung; 1969 Oct; 19(10):1691-8. PubMed ID: 5395369
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of vinca alkaloids on intestinal absorption of glucose.
    Das S; Yadav RK
    Indian J Physiol Pharmacol; 2002 Jan; 46(1):123-5. PubMed ID: 12024952
    [No Abstract]   [Full Text] [Related]  

  • 58. Cerebral vascular disorders: circulation and metabolism.
    Hossmann KA
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S2-4. PubMed ID: 7085790
    [No Abstract]   [Full Text] [Related]  

  • 59. [Experimental study on the cerebral circulation and metabolism in brain injury in the acute stage--with reference to substances relating to cell metabolism].
    Shibata T
    No To Shinkei; 1967 Mar; 19(3):231-40. PubMed ID: 6072083
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.